Patrick Ellison
Patrick Ellison writes for Floto Review and other Independent Journal publications, covering SEC filings and securities regulation and IPOs, direct listings and exchange listings. Reporting under this byline is prepared by the Independent Journal editorial desk from primary sources, with AI assistance, and reviewed under our editorial policy.
5 articles
Bluerock Acquisition II IPO Pricing: $150 Million, Trust at $10.05
Bluerock Acquisition Corp. II priced a $150 million SPAC IPO on Nasdaq that closed at $172.5 million, with a $10.05-a-unit trust and a 21-month deadline.
Reading a 424B4 final prospectus: a section-by-section guide
What a 424B4 final prospectus is, when it is filed, and how to read its cover page, underwriting, dilution and use of proceeds sections, step by step.
NorthStrive Acquisition IPO Pricing: $100 Million, Nasdaq
NorthStrive Acquisition Corp I priced a $100 million SPAC IPO at $10 a unit on Nasdaq and put the full amount in trust, with a 12-month window plus extensions.
Kardigan IPO Pricing: $400 Million Raised at $16 a Share
Cardiovascular biotech Kardigan priced 25 million shares at $16 in its June 2026 Nasdaq IPO. Our 424B4 review covers proceeds, pipeline, losses and cash.
Cerebras IPO Pricing Review: $185 a Share in the 424B4 Prospectus
Cerebras Systems priced 30 million Class A shares at $185 in its May 2026 IPO, raising $5.55 billion on Nasdaq. Our review of the final 424B4 prospectus.